The role of 18F-FDG PET/CT in the management of patients with secondary haemophagocytic lymphohistiocytosis

Clinical Radiology

Volumn 71, Issue 12, 2016, Pages 1248-1254

  Zheng, Y ^b   Hu, G ^a   Liu, Y ^a   Ma, Y ^a   Dang, Y ^a   Li, F ^a   Xing, H ^a   Wang, T ^a   Huo, L ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC VALUE; FEMALE; HEMOPHAGOCYTIC SYNDROME; HUMAN; LYMPHOMA; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PET-CT SCANNER; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SPLEEN MEDIASTINUM RATIO; SURVIVAL; DIAGNOSTIC IMAGING; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; PROCEDURES; REPRODUCIBILITY; SURVIVAL ANALYSIS; WHOLE BODY IMAGING; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; WHOLE BODY IMAGING; YOUNG ADULT;

EID: 84977080739     PISSN: 00099260     EISSN: 1365229X     Source Type: Journal    
DOI: 10.1016/j.crad.2016.05.011     Document Type: Article

References (29)

1. 1 Henter, J.I., Elinder, G., Soder, O., et al. Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis. Acta Paediatr Scand 80:4 (1991), 428–435.
2. 2 Janka, G.E., Familial and acquired hemophagocytic lymphohistiocytosis. Eur J Pediatr 166:2 (2007), 95–109.
3. 3 Mehta, R.S., Smith, R.E., Hemophagocytic lymphohistiocytosis (HLH): a review of literature. Medical Oncol, 30(4), 2013, 740.
4. 18F-FDG in the diagnosis and management of cancer patients. Int J Clin Oncol 11:4 (2006), 286–296.
5. 5 Corapcioglu, F., Oncel, S., Berberoglu, K., et al. False positivity of FDG-PET during hemophagocytic lymphohistiocytosis in a child with Hodgkin lymphoma in remission. J Pediatr Hematol Oncol 31:1 (2009), 74–75.
6. 6 Iyama, S., Matsunaga, T., Sato, T., et al. [A case of hepatosplenic gammadelta T-cell lymphoma associated hemophagocytic syndrome]. Gan To Kagaku Ryoho 35:9 (2008), 1623–1627.
7. 7 Suga, K., Kawakami, Y., Hiyama, A., et al. F-18 FDG PET/CT findings in a case of T-cell lymphoma-associated hemophagocytic syndrome with liver involvement. Clin Nucl Med 35:2 (2010), 116–120.
8. 8 Tai, C.F., Chang, L.Y., Lin, D.T., et al. A case of natural killer cell lymphoma presenting with bilateral pleural effusions and hemophagocytic lymphohistocytosis. Pediatr Blood Cancer 52:5 (2009), 666–669.
9. 18F-FDG PET/CT in secondary hemophagocytic lymphohistiocytosis. J Hematol Oncol, 5, 2012, 40.
10. 10 Henter, J.I., Horne, A., Arico, M., et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48:2 (2007), 124–131.
11. 18F-FDG PET and PET/CT in fever of unknown origin. J Nucl Med 48:1 (2007), 35–45.
12. 12 Weiler-Sagie, M., Bushelev, O., Epelbaum, R., et al. (18)F-FDG avidity in lymphoma readdressed: a study of 766 patients. J Nucl Med 51:1 (2010), 25–30.
13. 13 Kim, J., Yoo, S.W., Kang, S.R., et al. Clinical implication of F-18 FDG PET/CT in patients with secondary hemophagocytic lymphohistiocytosis. Ann Hematol 93:4 (2014), 661–667.
14. 14 Wang, J., Wang, D., Zhang, Q., et al. The significance of pre-therapeutic F-18-FDG PET/CT in lymphoma-associated hemophagocytic lymphohistiocytosis when pathological evidence is unavailable. J Cancer Res Clin Oncol 142:4 (2016), 859–871.
15. 15 Oh, J.R., Song, H.C., Kang, S.R., et al. The clinical usefulness of (18)F-FDG PET/CT in patients with systemic autoimmune disease. Nucl Med Mol Imaging 45:3 (2011), 177–184.
16. 16 Liu, Y., Clinical significance of diffusely increased splenic uptake on FDG-PET. Nucl Med Comm 30:10 (2009), 763–769.
17. 17 Wagner, T., Brechemier, D., Dugert, E., et al. Diffuse pulmonary uptake on FDG-PET with normal CT diagnosed as intravascular large B-cell lymphoma: a case report and a discussion of the causes of diffuse FDG uptake in the lungs. Cancer Imaging 12 (2012), 7–12.
18. 18 Rodrigues, R.S., Miller, P.R., Bozza, F.A., et al. FDG-PET in patients at risk for acute respiratory distress syndrome: a preliminary report. Intens Care Med 34:12 (2008), 2273–2278.
19. 19 von Rohr, L., Klaeser, B., Joerger, M., et al. Increased pulmonary FDG uptake in bleomycin-associated pneumonitis. Onkologie 30:6 (2007), 320–323.
20. 20 Inoue, K., Goto, R., Okada, K., et al. A bone marrow F-18 FDG uptake exceeding the liver uptake may indicate bone marrow hyperactivity. Ann Nucl Med 23:7 (2009), 643–649.
21. 21 Wang, C.S., Sun, C.F., C-reactive protein and malignancy: clinico-pathological association and therapeutic implication. Chang Gung Med J 32:5 (2009), 471–482.
22. 22 Janka, G.E., Familial and acquired hemophagocytic lymphohistiocytosis. Ann Rev Med 63 (2012), 233–246.
23. 23 Bode, S.F., Lehmberg, K., Maul-Pavicic, A., et al. Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis. Arthritis Res Ther, 14(3), 2012, 213.
24. 24 Lehmberg, K., Ehl, S., Diagnostic evaluation of patients with suspected haemophagocytic lymphohistiocytosis. Br J Haematol 160:3 (2013), 275–287.
25. 25 Li, F., Yang, Y., Jin, F., et al. Clinical characteristics and prognostic factors of adult hemophagocytic syndrome patients: a retrospective study of increasing awareness of a disease from a single-center in China. Orphanet J Rare Dis, 10(1), 2015, 20.
26. 26 Huang, W., Wang, Y., Wang, J., et al. [Clinical characteristics of 192 adult hemophagocytic lymphohistiocytosis]. Zhonghua xueyexue zazhi 35:9 (2014), 796–801.
27. 27 Weng, Y., Chen, N., Han, Y., et al. Clinical and laboratory characteristics of severe fever with thrombocytopenia syndrome in Chinese patients. Braz J Infect Dis 18:1 (2014), 88–91.
28. 28 Wluka, A., Olszewski, W.L., Innate and adaptive processes in the spleen. Ann Transplant 11:4 (2006), 22–29.
29. 29 Heikkila, K., Ebrahim, S., Rumley, A., et al. Associations of circulating C-reactive protein and interleukin-6 with survival in women with and without cancer: findings from the British Women's Heart and Health Study. Cancer Epidemiol Biomarkers Prev 16:6 (2007), 1155–1159.